rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
2005-11-21
|
pubmed:abstractText |
Golgi protein-73 (GP73) is up-regulated in hepatocellular carcinoma (HCC). The aims of this study were to determine if GP73 is detected in the serum, and to establish the sensitivity and specificity of serum GP73 for diagnosing HCC.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0168-8278
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
43
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1007-12
|
pubmed:dateRevised |
2008-9-11
|
pubmed:meshHeading |
pubmed-meshheading:16137783-Aged,
pubmed-meshheading:16137783-Biological Markers,
pubmed-meshheading:16137783-Carcinoma, Hepatocellular,
pubmed-meshheading:16137783-Female,
pubmed-meshheading:16137783-Humans,
pubmed-meshheading:16137783-Liver Cirrhosis,
pubmed-meshheading:16137783-Liver Neoplasms,
pubmed-meshheading:16137783-Male,
pubmed-meshheading:16137783-Membrane Proteins,
pubmed-meshheading:16137783-Middle Aged,
pubmed-meshheading:16137783-Sensitivity and Specificity,
pubmed-meshheading:16137783-alpha-Fetoproteins
|
pubmed:year |
2005
|
pubmed:articleTitle |
GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma.
|
pubmed:affiliation |
Division of Gastroenterology, University of Michigan Medical Center, 3912 Taubman Center, Ann Arbor, MI 48109-0362, USA. jmarrero@umich.edu
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|